2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures

This document describes the 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease, which were developed to guide clinicians, researchers, quality assurance personnel, payers, and regulatory agencies in the care of individuals with peripheral artery disease. The measures are designed to enable the assessment of the effects of treatment decisions, such as which medications should be used for individuals with peripheral artery disease and which tests are appropriate for follow-up after treatment interventions. The goal of this document is to help ensure that evidence-based care is offered to individuals with peripheral artery disease, and this care can be measured reliably and reproducibly across myriad care settings and populations.

Published by Journal of the American College of Cardiology, 2026. The guideline itself is at the source linked here.

doi.org/10.1016/j.jacc.2025.09.003